Web-based genome-wide association study identifies two novel loci and a substantial genetic component for parkinson's disease

PLoS Genetics

Volumn 7, Issue 6, 2011, Pages

  Do, Chuong B ^a   Tung, Joyce Y ^a   Dorfman, Elizabeth ^a   Kiefer, Amy K ^a   Drabant, Emily M ^a   Francke, Uta ^a   Mountain, Joanna L ^a   Goldman, Samuel M ^b   Tanner, Caroline M ^b   Langston, J William ^b   Wojcicki, Anne ^a   Eriksson, Nicholas ^a  

^a 23andMe ^*  (United States)

^b PARKINSON S INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; CYCLIN G; CYCLIN G ASSOCIATED KINASE; HLA ANTIGEN; LEUCINE RICH REPEAT KINASE 2; MEMBRANE PROTEIN; PROTEIN GBA; RETINOIC ACID INDUCIBLE PROTEIN I; SCAVENGER RECEPTOR B; SCAVENGER RECEPTOR B2; STEROL REGULATORY ELEMENT BINDING PROTEIN 1A; TAU PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HERITABILITY; HUMAN; MALE; PARKINSON DISEASE; PREDICTION; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; VALIDATION PROCESS; WEB BROWSER; FACTUAL DATABASE; GENE LOCUS; GENETIC PREDISPOSITION; GENETICS; HEREDITY; INTERNET; RISK ASSESSMENT;

DATABASES, FACTUAL; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HEREDITY; HUMANS; INTERNET; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT;

EID: 79959841853     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1002141     Document Type: Article

References (74)

1. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, et al. (1997) Mutation in the alphasynuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047.
2. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, et al. (2003) alpha-Synuclein locus triplication causes Parkinson's disease. Science 302: 841.
3. Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, et al. (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44: 595-600.
4. Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, et al. (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44: 601-607.
5. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, et al. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392: 605-608.
6. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, et al. (2004) Hereditary earlyonset Parkinson's disease caused by mutations in PINK1. Science 304: 1158-1160.
7. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, et al. (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299: 256-259.
8. Ramirez A, Heimbach A, Grndemann J, Stiller B, Hampshire D, et al. (2006) Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 38: 1184-1191.
9. Di Fonzo A, Chien HF, Socal M, Giraudo S, Tassorelli C, et al. (2007) ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease. Neurology 68: 1557-1562.
10. Tanner CM, Ottman R, Goldman SM, Ellenberg J, Chan P, et al. (1999) Parkinson disease in twins: an etiologic study. JAMA 281: 341-346.
11. Piccini P, Burn DJ, Ceravolo R, Maraganore D, Brooks DJ, (1999) The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins. Ann Neurol 45: 577-582.
12. Wirdefeldt K, Gatz M, Schalling M, Pedersen NL, (2004) No evidence for heritability of Parkinson disease in Swedish twins. Neurology 63: 305-311.
13. Farrer MJ, (2006) Genetics of Parkinson disease: paradigm shifts and future prospects. Nat Rev Genet 7: 306-318.
14. Sveinbjörnsdottir S, Hicks AA, Jonsson T, Pétursson H, Guǧmundsson G, et al. (2000) Familial aggregation of Parkinson's disease in Iceland. N Engl J Med 343: 1765-1770.
15. Pankratz N, Wilk JB, Latourelle JC, DeStefano AL, Halter C, et al. (2009) Genomewide association study for susceptibility genes contributing to familial Parkinson disease. Hum Genet 124: 593-605.
16. Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, et al. (2009) Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 41: 1308-1312.
17. Edwards TL, Scott WK, Almonte C, Burt A, Powell EH, et al. (2010) Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet 74: 97-109.
18. Hamza TH, Zabetian CP, Tenesa A, Laederach A, Montimurro J, et al. (2010) Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet 42: 781-785.
19. Spencer CC, Plagnol V, Strange A, Gardner M, Paisan-Ruiz C, et al. (2011) Dissection of the genetics of Parkinson's disease identifies an additional association 5′ of SNCA and multiple associated haplotypes at 17q21. Hum Mol Genet 20: 345-353.
20. Satake W, Nakabayashi Y, Mizuta I, Hirota Y, Ito C, et al. (2009) Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 41: 1303-1307.
21. Saad M, Lesage S, Saint-Pierre A, Corvol JC, Zelenika D, et al. (2011) Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population. Hum Mol Genet 20: 615-627.
22. Nalls MA, Plagnol V, Hernandez DG, Sharma M, Sheerin UM, et al. (2011) Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 377: 641-649.
23. International Parkinson Disease Genomics Consortium (2011) Tbd. TBD.
24. Healy DG, Falchi M, O'Sullivan SS, Bonifati V, Durr A, et al. (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol 7: 583-590.
25. Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, et al. (2009) Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med 361: 1651-1661.
26. Nichols WC, Pankratz N, Marek DK, Pauciulo MW, Elsaesser VE, et al. (2009) Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset. Neurology 72: 310-316.
27. Lill C, Roehr J, McQueen M, Bagade S, Kavvoura F, et al. The PDGene database, Alzheimer research forum. Available at: pdgene.org. Accessed Nov. 18, 2010.
28. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, et al. (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 106: 9362-9367.
29. Yang J, Lee SH, Goddard ME, Visscher PM, (2011) GCTA: A Tool for Genome-wide Complex Trait Analysis. Am J Hum Genet 88: 76-82.
30. Lee SH, Wray NR, Goddard ME, Visscher PM, (In press) Estimating missing heritability for disease from genome-wide association studies. Am J Hum Genet.
31. Wray NR, Yang J, Goddard ME, Visscher PM, (2010) The genetic interpretation of area under the ROC curve in genomic profiling. PLoS Genet 6: e1000864 doi:10.1371/journal.pgen.1000864.
32. Kooperberg C, LeBlanc M, Obenchain V, (2010) Risk prediction using genome-wide association studies. Genet Epidemiol 34: 643-652.
33. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, et al. (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460: 748-752.
34. Berkovic SF, Dibbens LM, Oshlack A, Silver JD, Katerelos M, et al. (2008) Array-based gene discovery with three unrelated subjects shows SCARB2/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis. Am J Hum Genet 82: 673-684.
35. Reczek D, Schwake M, Schroder J, Hughes H, Blanz J, et al. (2007) LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase. Cell 131: 770-783.
36. Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R, (2004) Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N Engl J Med 351: 1972-1977.
37. Brown MS, Goldstein JL, (1997) The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89: 331-340.
38. Taghibiglou C, Martin HG, Lai TW, Cho T, Prasad S, et al. (2009) Role of NMDA receptordependent activation of SREBP1 in excitotoxic and ischemic neuronal injuries. Nat Med 15: 1399-1406.
39. Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, et al. (1993) SREBP-1, a basic-helix-loophelix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell 75: 187-197.
40. Slager RE, Newton TL, Vlangos CN, Finucane B, Elsea SH, (2003) Mutations in RAI1 associated with Smith-Magenis syndrome. Nat Genet 33: 466-468.
41. Lee CH, Della NG, Chew CE, Zack DJ, (1996) Rin, a neuron-specific and calmodulin-binding small G-protein, and Rit define a novel subfamily of ras proteins. J Neurosci 16: 6784-6794.
42. Mosharov EV, Larsen KE, Kanter E, Phillips KA, Wilson K, et al. (2009) Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons. Neuron 62: 218-229.
43. Ferguson GD, Chen XN, Korenberg JR, Herschman HR, (2000) The human synaptotagmin IV gene defines an evolutionary break point between syntenic mouse and human chromosome regions but retains ligand inducibility and tissue specificity. J Biol Chem 275: 36920-36926.
44. Ferguson GD, Anagnostaras SG, Silva AJ, Herschman HR, (2000) Deficits in memory and motor performance in synaptotagmin IV mutant mice. Proc Natl Acad Sci USA 97: 5598-5603.
45. Huynh DP, Scoles DR, Nguyen D, Pulst SM, (2003) The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI. Hum Mol Genet 12: 2587-2597.
46. Li Y, Schrodi S, Rowland C, Tacey K, Catanese J, et al. (2006) Genetic evidence for ubiquitinspecific proteases USP24 and USP40 as candidate genes for late-onset Parkinson disease. Hum Mutat 27: 1017-1023.
47. Alcalay RN, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, et al. (2010) Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. Arch Neurol 67: 1116-1122.
48. Moilanen JS, Autere JM, Myllyla VV, Majamaa K, (2001) Complex segregation analysis of Parkinson's disease in the Finnish population. Hum Genet 108: 184-189.
49. Yang J, Visscher PM, Wray NR, (2010) Sporadic cases are the norm for complex disease. Eur J Hum Genet 18: 1039-1043.
50. Payami H, Larsen K, Bernard S, Nutt J, (1994) Increased risk of Parkinson's disease in parents and siblings of patients. Ann Neurol 36: 659-661.
51. Shino MY, McGuire V, Van Den Eeden SK, Tanner CM, Popat R, et al. (2010) Familial aggregation of Parkinson's disease in a multiethnic community-based case-control study. Mov Disord 25: 2587-2594.
52. Falush D, Stephens M, Pritchard JK, (2003) Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 164: 1567-1587.
53. Eriksson N, Macpherson JM, Tung JY, Hon LS, Naughton B, et al. (2010) Web-based, participantdriven studies yield novel genetic associations for common traits. PLoS Genet 6: e1000993 doi:10.1371/journal.pgen.1000993.
54. Fung HC, Scholz S, Matarin M, Simon-Sanchez J, Hernandez D, et al. (2006) Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol 5: 911-916.
55. Simon-Sanchez J, Scholz S, Fung HC, Matarin M, Hernandez D, et al. (2007) Genome-wide SNP assay reveals structural genomic variation, extended homozygosity and cell-line induced alterations in normal individuals. Hum Mol Genet 16: 1-14.
56. Wigginton JE, Cutler DJ, Abecasis GR, (2005) A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 76: 887-893.
57. Hindorff L, Junkins H, Hall P, Mehta J, Manolio T, A catalog of published genome-wide association studies. Available at: www.genome.gov/gwastudies. Accessed Nov. 18, 2010.
58. Freidlin B, Zheng G, Li Z, Gastwirth JL, (2002) Trend tests for case-control studies of genetic markers: power, sample size and robustness. Hum Hered 53: 146-152.
59. Zou H, Hastie T, (2005) Regularization and variable selection via the Elastic Net. Journal of the Royal Statistical Society B 67: 301-320.
60. Cho S, Kim H, Oh S, Kim K, Park T, (2009) Elastic-net regularization approaches for genome-wide association studies of rheumatoid arthritis. BMC Proc 3 (Suppl 7): S25.
61. Guzzetta G, Jurman G, Furlanello C, (2010) A machine learning pipeline for quantitative phenotype prediction from genotype data. BMC Bioinformatics 11 (Suppl 8): S3.
62. Neuman RJ, Sung YJ, (2009) Multistage analysis strategies for genome-wide association studies: summary of group 3 contributions to Genetic Analysis Workshop 16. Genet Epidemiol 33 (Suppl 1): 19-23.
63. Hoggart CJ, Whittaker JC, De Iorio M, Balding DJ, (2008) Simultaneous analysis of all SNPs in genome-wide and re-sequencing association studies. PLoS Genet 4: e1000130 doi:10.1371/journal.pgen.1000130.
64. Cook NR, (2007) Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115: 928-935.
65. Pepe MS, Janes HE, (2008) Gauging the performance of SNPs, biomarkers, and clinical factors for predicting risk of breast cancer. J Natl Cancer Inst 100: 978-979.
66. Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, et al. (2010) Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 21: 128-138.
67. Hand DJ, (2010) Evaluating diagnostic tests: The area under the ROC curve and the balance of errors. Stat Med 29: 1502-1510.
68. Janssens AC, Khoury MJ, (2010) Assessment of improved prediction beyond traditional risk factors:when does a difference make a difference? Circ Cardiovasc Genet 3: 3-5.
69. Yang J, Benyamin B, McEvoy BP, Gordon S, Henders AK, et al. (2010) Common SNPs explain a large proportion of the heritability for human height. Nat Genet 42: 565-569.
70. Genz A, (1992) Numerical computation of multivariate normal probabilities. J Comput Graph Stat 1: 141-149.
71. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, et al. (2010) LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26: 2336-2337.
72. Ioannidis JP, Boffetta P, Little J, O'Brien TR, Uitterlinden AG, et al. (2008) Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol 37: 120-132.
73. Hamza TH, Payami H, (2010) The heritability of risk and age at onset of Parkinson's disease after accounting for known genetic risk factors. J Hum Genet 55: 241-243.
74. Payami H, Zareparsi S, James D, Nutt J, (2002) Familial aggregation of Parkinson disease: a comparative study of early-onset and late-onset disease. Arch Neurol 59: 848-850.